Chordoma cancer stem cell subpopulation characterization may guide targeted immunotherapy approaches to reduce disease recurrence

IntroductionCancer stem cells (CSCs), a group of tumor-initiating and tumor-maintaining cells, may be major players in the treatment resistance and recurrence distinctive of chordoma. Characterizing CSCs is crucial to better targeting this subpopulation.MethodsUsing flow cytometry, six chordoma cell...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Diana C. Lopez, Kellsye P. Fabian, Michelle R. Padget, Yvette L. Robbins, Joshua T. Kowalczyk, Wiem Lassoued, Danielle M. Pastor, Clint T. Allen, Gary L. Gallia, James L. Gulley, James W. Hodge, Nyall R. London
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2024-04-01
Colecção:	Frontiers in Oncology
Assuntos:	chordoma cancer stem cells (CSC) tumor microenvironment (TME) immunotherapy PD-L1
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1376622/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!